¹û¶³´«Ã½

AbbVie-lutely fabulous

The pharma giant’s diversified portfolio has been bolstered by its $63bn Allergan takeover

¹û¶³´«Ã½ Farm: Which letter matters most in ESG?

Ticking the right ESG boxes is fine, but new research suggests a way to identify companies that are grasping the real opportunities

Life after Wirecard: should you buy Darwall's investment trust?

Does Alexander Darwall's approach still warrant confidence?

Hunting: playing catch-up

The oil services group’s shares have been slow to respond to the rising oil price, and that’s an opportunity, says Michael Taylor

Six cheap growth shares

2021’s selection of John Neff-inspired stocks show some more promising growth characteristics.

¹û¶³´«Ã½ Farm: If I were a crook...

A better plan for skulduggery than short selling.

Ashtead looks well equipped for further growth

The equipment rental company has reduced its cyclical exposure since the last recession

Shanta Gold unshackled for 2021

As the gold bull run goes on, the East African gold miner has been able to buy a major new asset, move into a net cash position and start work on the Singida mine. All that's left is a payout for shareholders

Restaurant Group: Prepare for Covid-cues

Michael Taylor explains why even some of the worst companies can present opportunities for traders

¹û¶³´«Ã½ Farm: What to do when your fund doubles?

Is it time to bail from shoot-the-lights out funds?